Search

for
Search:

Sort by

Research

90-120 / 1000+ results

Efficacy of a Wheat Polar Lipid Complex in Reducing Hair Loss and Improving Hair Growth in Healthy Women: A Randomized, Double-Blind, Placebo-Controlled Clinical Study

research Efficacy of a wheat polar lipid complex in reducing hair loss and improving hair growth in healthy women: A randomized, double‐blind, placebo‐controlled clinical study

November 2023 in “International Journal of Cosmetic Science”

Wheat polar lipid complex reduces hair loss and improves hair growth in women.

Efficacy and Safety of Topical KX-826 in Male Subjects with Androgenetic Alopecia: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase II Study

research 587 Efficacy and Safety of topical KX-826 in Male Subjects with Androgenetic Alopecia:A Multicenter, Randomized, Double-blind, Placebo-controlled Phase II Study

November 2022 in “Journal of Investigative Dermatology”

KX-826 is safe and effectively increases hair count in men with hair loss.

research Effect and mechanism of YH0618 granule on chemotherapy- induced hair loss in patients with breast cancer: study protocol for a randomized, double-blind, multi-center clinical trial

October 2019 in “Research Square (Research Square)”

YH0618 granules may help prevent hair loss in breast cancer patients undergoing chemotherapy.

research Effect and mechanism of YH0618 granule on chemotherapy- induced hair loss in patients with breast cancer: study protocol for a randomized, double-blind, multi-center clinical trial

October 2019 in “Research Square (Research Square)”

YH0618 granules may help prevent hair loss in breast cancer patients undergoing chemotherapy.

research Effect and mechanism of YH0618 granule on chemotherapy- induced hair loss in patients with breast cancer: study protocol for a randomized, double-blind, multi-center clinical trial

June 2019 in “Research Square (Research Square)”

YH0618 granules may help prevent hair loss in breast cancer patients undergoing chemotherapy.

Efficacy and Safety of a Low-Level Laser Device in the Treatment of Male and Female Pattern Hair Loss: A Multicenter, Randomized, Sham Device-Controlled, Double-Blind Study

research Efficacy and Safety of a Low-level Laser Device in the Treatment of Male and Female Pattern Hair Loss: A Multicenter, Randomized, Sham Device-controlled, Double-blind Study

147 citations , January 2014 in “American Journal of Clinical Dermatology”

Laser device increases hair density, safe for treating hair loss in men and women.

Comparative Study to Evaluate Tolerability of Topical 5% Minoxidil Novel Formulation and Alcohol-Based Conventional Solutions in Treatment of Androgenetic Alopecia in Indian Men: Randomized Double-Blind Study

research Comparative Study to Evaluate Tolerability of Topical 5% Minoxidil Novel Formulation and Alcohol-Based Conventional Solutions in Treatment of Androgenetic Alopecia in Indian Men: Randomized Double-Blind Study

April 2020 in “Dermatology and therapy”

New 5% minoxidil solution improves scalp hydration, reduces redness, and may be safer for sensitive users.

Efficacy, Safety, and Tolerability of Dutasteride 0.5 mg Once Daily in Male Patients with Male Pattern Hair Loss: A Randomized, Double-Blind, Placebo-Controlled, Phase III Study

research Efficacy, safety, and tolerability of dutasteride 0.5 mg once daily in male patients with male pattern hair loss: A randomized, double-blind, placebo-controlled, phase III study

92 citations , June 2010 in “Journal of The American Academy of Dermatology”

Dutasteride 0.5 mg daily improves hair growth safely in men with hair loss.

Curcuma Aeruginosa, A Novel Botanically Derived 5α-Reductase Inhibitor In The Treatment Of Male-Pattern Baldness: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study

research Curcuma aeruginosa, a novel botanically derived 5α-reductase inhibitor in the treatment of male-pattern baldness: a multicenter, randomized, double-blind, placebo-controlled study

34 citations , July 2011 in “Journal of Dermatological Treatment”

Curcuma aeruginosa extract combined with minoxidil effectively treats male-pattern baldness.

Evaluation of Efficacy of Water-Soluble Fraction of Rhus Semialata Gall Extract and Penta-O-Galloyl-β-D-Glucose on Mitigation of Hair Loss: An In Vitro and Randomized Double-Blind Placebo-Controlled Clinical Study

research Evaluation of Efficacy of Water-Soluble Fraction of Rhus semialata Gall Extract and Penta-O-Galloyl-β-D-Glucose on Mitigation of Hair Loss: An In Vitro and Randomized Double-Blind Placebo-Controlled Clinical Study

April 2025 in “Antioxidants”

Rhus semialata gall extract and Penta-O-Galloyl-β-D-Glucose may effectively reduce hair loss.

Efficacy and Safety of Topical Finasteride Spray Solution in the Treatment of Chinese Men with Androgenetic Alopecia: A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study

research Efficacy and safety of topical finasteride spray solution in the treatment of Chinese men with androgenetic alopecia: A phase III, multicenter, randomized, double-blind, placebo-controlled study

March 2025 in “Chinese Medical Journal”

Topical finasteride effectively and safely increases hair growth in men with hair loss.

research CG210 Enables Finasteride 1mg Users to Further Improve Hair Pattern: A Randomized, Double-Blind, Placebo-Controlled Pilot Study

1 citations , January 2013 in “Hair therapy & transplantation”

The document does not provide information about hair loss treatment.

Safety and Clinical Efficacy of Kūlaris, an Herbal Supplement for Mild to Severe Acne Vulgaris: A 12-Week Randomized, Double-Blind, Placebo-Controlled Study

research Safety and Clinical Efficacy of KūlarisTM, an Herbal Supplement for Mild to Severe Acne Vulgaris – A 12-Week Randomized, Double Blind, Placebo-Controlled Study

September 2025 in “Clinical Cosmetic and Investigational Dermatology”

Kūlaris improved quality of life for acne sufferers without side effects.

Oral Supplementation With L-Cystine, Serenoa Repens, Pumpkin Seed Oil, And Pygeum Africanum In Chronic Telogen Effluvium And Androgenetic Alopecia: A Double-Blind, Placebo-Controlled, Randomized Clinical Study

research 51252 Oral supplementation with L-Cystine, Serenoa repens, Pumpkin seed oil and Pygeum africanum in Chronic Telogen Effluvium and Androgenetic Alopecia: A double-blind, placebo-controlled, randomized clinical study

September 2024 in “Journal of the American Academy of Dermatology”

The supplements improved hair density and reduced hair loss.

Effect of Applying Lactiplantibacillus Plantarum Subsp. Plantarum N793 to the Scalps of Men and Women with Thinning Hair: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study

research Effect of applying Lactiplantibacillus plantarum subsp. plantarum N793 to the scalps of men and women with thinning hair: a randomized, double-blind, placebo-controlled, parallel-group study

January 2024 in “BMFH”

N793 may improve hair density in people with mild hair thinning.

research 42134 Long-term Efficacy of Guselkumab (GUS) on Fatigue and Identification of Early Treatment Targets: Post Hoc Analysis Through 2 Years of a Phase 3, Randomized, Double-blind, Placebo-controlled Study in Biologic-naïve Patients With Psoriatic Arthritis (PsA)

September 2023 in “Journal of the American Academy of Dermatology”

Guselkumab effectively reduces fatigue in Psoriatic Arthritis patients over two years.

research FASCE, the benefit of spironolactone for treating acne in women: study protocol for a randomized double-blind trial

9 citations , June 2020 in “Trials”

The trial aims to test if spironolactone is an effective acne treatment for women without the side effects of current treatments.

research Clinical assessment of CL22209, a standardized proprietary extract of Asparagus racemosus, for mitigating vasomotor and menstrual symptoms in perimenopausal women: A randomized, double-blind, placebo-controlled study

1 citations , July 2025 in “Functional Foods in Health and Disease”

CL22209, an Asparagus racemosus extract, safely reduces perimenopausal symptoms and balances hormones.

research Faculty Opinions recommendation of Efficacy and safety of a low-level laser device in the treatment of male and female pattern hair loss: a multicenter, randomized, sham device-controlled, double-blind study.

February 2014 in “Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature”

research Commentary on Clinical Safety and Efficacy of Dual Wavelength Low Level Light Therapy in Androgenetic Alopecia; A Double-Blind Randomized Controlled Study

December 2024 in “Dermatologic Surgery”

research Comparison of efficacy of platelet-rich plasma therapy with or without topical 5% minoxidil in male-type baldness: A randomized, double-blind placebo control trial

26 citations , December 2019 in “Indian Journal of Dermatology, Venereology and Leprology”

PRP combined with minoxidil is the most effective and safe treatment for male pattern baldness.

research A Double Blind Randomized Placebo Controlled Clinical Trial of Finasteride in the Treatment of Androgenetic Alopecia

2 citations , January 2002 in “The Chinese Journal of Clinical Pharmacology”

Finasteride effectively improves hair growth in men with minimal side effects.

research Multicenter double blind randomized placebo controlled clinical trial of minoxidil gel in the treatment of alopecia areata

January 2006 in “The Chinese Journal of Clinical Pharmacology”

2.2% minoxidil gel effectively and safely treats alopecia areata.

research A Randomized Double‐Blind Controlled Evaluation of the Therapeutic Benefits of an Herbal Lip Hydrant

2 citations , February 2025 in “Journal of Cosmetic Dermatology”

The herbal lip hydrant is more effective than petroleum gel for improving lip hydration and reducing chapped lips.

research The randomized double-blind placebo-controlled trial of intralesional botulinum toxin A injection for recalcitrant alopecia totalis and alopecia universalis

1 citations , March 2012 in “Journal of the American Academy of Dermatology”

Botulinum toxin A injections may help treat difficult cases of total hair loss.

A Randomized Double-Blind Placebo-Controlled Clinical Trial to Evaluate the Effect of an Annurca Apple Supplement Formula in Androgenic Alopecia

research A randomized double-blind placebo-controlled clinical trial to evaluate the effect of an Annurca apple supplement formula in androgenic alopecia

May 2023 in “Journal of Applied Cosmetology”

The Annurca apple supplement significantly improved hair growth in people with hair loss.

research A Randomized Double-Blind Evaluation of a Novel Biotin and Silicon Ingredient Complex on the Hair and Skin of Healthy Women

January 2021 in “Journal of clinical & experimental dermatology research”

LustrivaTM improves hair thickness and reduces facial wrinkles safely.

Treatment of Alopecia Areata with Topical Corticosteroid: Prospective Double-Blind Randomized Study in Children

research Tratamento da alopecia areata com corticóide tópico: estudo prospectivo randomizado duplo cego em crianças * Therapy of alopecia areata with topical corticosteroid: prospective double-blind controlled assay in children *

January 2003

Topical corticosteroid treatment showed no significant difference from placebo in treating alopecia areata in children.

research Randomized, double‐blind clinical evaluation of the efficacy and safety of topical eflornithine HCl 13.9% cream in the treatment of women with facial hair

133 citations , July 2006 in “International Journal of Dermatology”

The cream effectively and safely reduces facial hair in women.

research Double-blind, randomized, placebo-controlled trial of a cream containing theStryphnodendron adstringens(Martius) Coville bark extract for suppressing terminal hair growth

9 citations , January 2009 in “Journal of the European Academy of Dermatology and Venereology”

The cream effectively reduces excessive hair growth and related skin issues without side effects.

← Previous page Next page →

Search

for
Search:

Research

research Efficacy of a wheat polar lipid complex in reducing hair loss and improving hair growth in healthy women: A randomized, double‐blind, placebo‐controlled clinical study

research 587 Efficacy and Safety of topical KX-826 in Male Subjects with Androgenetic Alopecia:A Multicenter, Randomized, Double-blind, Placebo-controlled Phase II Study

research Effect and mechanism of YH0618 granule on chemotherapy- induced hair loss in patients with breast cancer: study protocol for a randomized, double-blind, multi-center clinical trial

research Effect and mechanism of YH0618 granule on chemotherapy- induced hair loss in patients with breast cancer: study protocol for a randomized, double-blind, multi-center clinical trial

research Effect and mechanism of YH0618 granule on chemotherapy- induced hair loss in patients with breast cancer: study protocol for a randomized, double-blind, multi-center clinical trial

research Efficacy and Safety of a Low-level Laser Device in the Treatment of Male and Female Pattern Hair Loss: A Multicenter, Randomized, Sham Device-controlled, Double-blind Study

research Comparative Study to Evaluate Tolerability of Topical 5% Minoxidil Novel Formulation and Alcohol-Based Conventional Solutions in Treatment of Androgenetic Alopecia in Indian Men: Randomized Double-Blind Study

research Efficacy, safety, and tolerability of dutasteride 0.5 mg once daily in male patients with male pattern hair loss: A randomized, double-blind, placebo-controlled, phase III study

research Curcuma aeruginosa, a novel botanically derived 5α-reductase inhibitor in the treatment of male-pattern baldness: a multicenter, randomized, double-blind, placebo-controlled study

research Evaluation of Efficacy of Water-Soluble Fraction of Rhus semialata Gall Extract and Penta-O-Galloyl-β-D-Glucose on Mitigation of Hair Loss: An In Vitro and Randomized Double-Blind Placebo-Controlled Clinical Study

research Efficacy and safety of topical finasteride spray solution in the treatment of Chinese men with androgenetic alopecia: A phase III, multicenter, randomized, double-blind, placebo-controlled study

research CG210 Enables Finasteride 1mg Users to Further Improve Hair Pattern: A Randomized, Double-Blind, Placebo-Controlled Pilot Study

research Safety and Clinical Efficacy of KūlarisTM, an Herbal Supplement for Mild to Severe Acne Vulgaris – A 12-Week Randomized, Double Blind, Placebo-Controlled Study

research 51252 Oral supplementation with L-Cystine, Serenoa repens, Pumpkin seed oil and Pygeum africanum in Chronic Telogen Effluvium and Androgenetic Alopecia: A double-blind, placebo-controlled, randomized clinical study

research Effect of applying <i>Lactiplantibacillus plantarum</i> subsp. <i>plantarum</i> N793 to the scalps of men and women with thinning hair: a randomized, double-blind, placebo-controlled, parallel-group study

research 42134 Long-term Efficacy of Guselkumab (GUS) on Fatigue and Identification of Early Treatment Targets: Post Hoc Analysis Through 2 Years of a Phase 3, Randomized, Double-blind, Placebo-controlled Study in Biologic-naïve Patients With Psoriatic Arthritis (PsA)

research FASCE, the benefit of spironolactone for treating acne in women: study protocol for a randomized double-blind trial

research Clinical assessment of CL22209, a standardized proprietary extract of <i>Asparagus racemosus</i>, for mitigating vasomotor and menstrual symptoms in perimenopausal women: A randomized, double-blind, placebo-controlled study

research Faculty Opinions recommendation of Efficacy and safety of a low-level laser device in the treatment of male and female pattern hair loss: a multicenter, randomized, sham device-controlled, double-blind study.

research Commentary on Clinical Safety and Efficacy of Dual Wavelength Low Level Light Therapy in Androgenetic Alopecia; A Double-Blind Randomized Controlled Study

research Comparison of efficacy of platelet-rich plasma therapy with or without topical 5% minoxidil in male-type baldness: A randomized, double-blind placebo control trial

research A Double Blind Randomized Placebo Controlled Clinical Trial of Finasteride in the Treatment of Androgenetic Alopecia

research Multicenter double blind randomized placebo controlled clinical trial of minoxidil gel in the treatment of alopecia areata

research A Randomized Double‐Blind Controlled Evaluation of the Therapeutic Benefits of an Herbal Lip Hydrant

research The randomized double-blind placebo-controlled trial of intralesional botulinum toxin A injection for recalcitrant alopecia totalis and alopecia universalis

research A randomized double-blind placebo-controlled clinical trial to evaluate the effect of an Annurca apple supplement formula in androgenic alopecia

research A Randomized Double-Blind Evaluation of a Novel Biotin and Silicon Ingredient Complex on the Hair and Skin of Healthy Women

research Tratamento da alopecia areata com corticóide tópico: estudo prospectivo randomizado duplo cego em crianças * Therapy of alopecia areata with topical corticosteroid: prospective double-blind controlled assay in children *

research Randomized, double‐blind clinical evaluation of the efficacy and safety of topical eflornithine HCl 13.9% cream in the treatment of women with facial hair

research Double-blind, randomized, placebo-controlled trial of a cream containing theStryphnodendron adstringens(Martius) Coville bark extract for suppressing terminal hair growth